SCHEMBL6236517

SCHEMBL6236517

c1cncc(-c2cnc3nc(-c4cccs4)c(-c4cccs4)nc3c2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.55
CYP2E1 P05181 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2B6 P20813 1/20 0.55
KDM4E B2RXH2 4/20 0.47
HSD17B10 Q99714 3/20 0.47
MAPK1 P28482 1/20 0.47
DYRK1A Q13627 3/20 0.46
CLK2 P49760 1/20 0.46
CLK3 P49761 1/20 0.46
RPS6KB2 Q9UBS0 6/20 0.46
ALDH1A1 P00352 3/20 0.45
HPGD P15428 2/20 0.45
RAB9A P51151 1/20 0.45
TP53 P04637 1/20 0.43
PDGFRB P09619 2/20 0.43
PDGFRA P16234 2/20 0.43
EGFR P00533 1/20 0.43
DYRK1B Q9Y463 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6237105 0.88 RPS6KB2 (0.49) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL6236374 0.85 RPS6KB2 (0.54) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL6240193 0.81 MAPT (0.51) CYP3A4CYP2C9DYRK1ACLK2CLK3
SCHEMBL6237798 0.81 RPS6KB2 (0.52) DYRK1ARPS6KB2PDGFRBPDGFRADYRK1B
SCHEMBL6256213 0.76 RPS6KB2 (0.60) KDM4EHSD17B10MAPK1RPS6KB2ALDH1A1
SCHEMBL6240032 0.76 RPS6KB2 (0.42) CYP3A4CYP2C9HSD17B10MAPK1RPS6KB2
SCHEMBL6239563 0.75 RPS6KB2 (0.53) CYP3A4CYP2C9KDM4EHSD17B10MAPK1
SCHEMBL6236199 0.75 RPS6KB2 (0.41) CYP3A4CYP2C9HSD17B10MAPK1RPS6KB2
SCHEMBL6234238 0.75 RPS6KB2 (0.44) CYP3A4CYP2C9KDM4EHSD17B10MAPK1
SCHEMBL6237157 0.74 RPS6KB2 (0.54) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005007099-A2 PKB INHIBITORS AS ANTI-TUMOR AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-27 WO disclosed